ATR 1072
/ Atrium Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 18, 2026
ATR 1072 in Participants With PRKAG2 Syndrome
(clinicaltrials.gov)
- P1/2 | N=37 | Recruiting | Sponsor: Atrium Therapeutics | Not yet recruiting ➔ Recruiting
Enrollment open • First-in-human • Cardiomyopathy • Cardiovascular • CNS Disorders • Hypertrophic Cardiomyopathy • Movement Disorders
August 01, 2026
ATR 1072 in Participants With PRKAG2 Syndrome
(clinicaltrials.gov)
- P1/2 | N=37 | Not yet recruiting | Sponsor: Atrium Therapeutics
New P1/2 trial • Cardiomyopathy • Cardiovascular • CNS Disorders • Hypertrophic Cardiomyopathy • Movement Disorders
1 to 2
Of
2
Go to page
1